Albemarle Corporation announces resignation of board member

Albemarle Corporation reported a change in its board leadership.

Rhea-AI Filing Summary

Albemarle Corporation reported a change in its board leadership. On December 8, 2025, director Dean L. Seavers submitted his resignation from the company’s Board of Directors and from all committees on which he serves, with the resignation to become effective on December 12, 2025. The company stated that his decision to resign is not related to any disagreement regarding Albemarle’s operations, policies, or practices. This indicates a governance change without an identified dispute over the company’s direction or management approach.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did Albemarle Corporation (ALB) announce?

Albemarle Corporation announced that Dean L. Seavers resigned from its Board of Directors and all related committees, effective December 12, 2025.

Did Albemarle (ALB) report any disagreement linked to Dean L. Seavers’ resignation?

No. The company stated that his resignation is not related to any disagreement regarding Albemarle’s operations, policies, or practices.

When did Dean L. Seavers submit his resignation from Albemarle’s board?

Dean L. Seavers tendered his resignation on December 8, 2025, with an effective date of December 12, 2025.

Which committees did Dean L. Seavers leave at Albemarle Corporation?

He resigned from all committees of the Albemarle Corporation Board of Directors on which he served.

Who signed the Albemarle 8-K reporting the director resignation?

The report was signed on behalf of Albemarle Corporation by Ander C. Krupa, General Counsel and Corporate Secretary.

Does this Albemarle 8-K include any financial results or major transactions?

No. The disclosure focuses on the resignation of a director and does not provide earnings data or major transaction details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/12/2025 - 04:16 PM EST Learn about SEC filing dates

false000091591300009159132025-12-082025-12-080000915913us-gaap:CommonStockMember2025-12-082025-12-080000915913us-gaap:SeriesAPreferredStockMember2025-12-082025-12-08

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________________

FORM 8-K

_________________________________

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 8, 2025

_________________________________

ALBEMARLE CORPORATION

(Exact name of registrant as specified in charter)

_________________________________

Virginia

001-12658

54-1692118

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

4250 Congress Street, Suite 900

Charlotte, North Carolina 28209

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (980) 299-5700

Not applicable

(Former name or former address, if changed since last report.)

_________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a- 12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

COMMON STOCK, $.01 Par Value

ALB

New York Stock Exchange

DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock

ALB PR A

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On December 8, 2025, Dean L. Seavers tendered his resignation from the Board of Directors of Albemarle Corporation and all committees on which he serves, effective December 12, 2025. His resignation is not related to any disagreement regarding the organization’s operations, policies, or practices..

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						ALBEMARLE CORPORATION
Date: December 12, 2025						By:			/s/ Ander C. Krupa
									Ander C. Krupa
									General Counsel and Corporate Secretary